Expression/NN
and/CC
genomic/JJ
configuration/NN
of/IN
GM-CSF/NN
,/,
IL-3/NN
,/,
M-CSF/NN
receptor/NN
(/(
C-FMS/NN
)/)
,/,
early/JJ
growth/NN
response/NN
gene-1/NN
(/(
EGR-1/NN
)/)
and/CC
M-CSF/NN
genes/NNS
in/IN
primary/JJ
myelodysplastic/JJ
syndromes/NNS
./.

Peripheral/JJ
blood/NN
mononuclear/JJ
cells/NNS
from/IN
seventeen/CD
patients/NNS
with/IN
primary/JJ
myelodysplastic/JJ
syndromes/NNS
(/(
MDS/NN
)/)
in/IN
advanced/JJ
stage/NN
were/VBD
enriched/JJ
for/IN
blasts/NNS
and/CC
tested/VBN
for/IN
(/(
1/LS
)/)
karyotype/NN
,/,
(/(
2/LS
)/)
genomic/JJ
configuration/NN
and/CC
(/(
3/LS
)/)
expression/NN
of/IN
IL-3/NN
,/,
GM-CSF/NN
,/,
FMS/NN
and/CC
EGR-1/NN
genes/NNS
which/WDT
are/VBP
all/DT
located/JJ
on/IN
the/DT
long/JJ
arm/NN
of/IN
chromosome/NN
5/CD
./.
=====
The/DT
expression/NN
of/IN
the/DT
M-CSF/NN
gene/NN
,/,
that/WDT
has/VBZ
been/VBN
recently/RB
reassigned/VBN
to/TO
the/DT
short/JJ
arm/NN
of/IN
chromosome/NN
1/CD
(/(
lp/NN
)/)
,/,
was/VBD
also/RB
investigated/VBN
./.
=====
Aims/NNS
of/IN
the/DT
study/NN
were/VBD
to/TO
(/(
1/LS
)/)
assess/VB
the/DT
potential/JJ
role/NN
of/IN
the/DT
expression/NN
of/IN
these/DT
genes/NNS
in/IN
the/DT
maintenance/NN
and/CC
expansion/NN
of/IN
the/DT
neoplastic/JJ
clones/NNS
and/CC
(/(
2/LS
)/)
search/VB
for/IN
constitutional/JJ
losses/NNS
or/CC
rearrangements/NNS
of/IN
one/CD
allele/NN
followed/VBN
by/IN
a/DT
deletion/NN
of/IN
the/DT
second/JJ
allele/NN
of/IN
the/DT
same/JJ
genes/NNS
in/IN
the/DT
leukemic/JJ
cells/NNS
./.
=====
The/DT
latter/JJ
issue/NN
was/VBD
investigated/VBN
by/IN
comparing/VBG
,/,
in/IN
8/CD
cases/NNS
,/,
constitutive/JJ
DNA/NN
from/IN
skin/NN
fibroblasts/NNS
with/IN
leukemic/JJ
DNA/NN
./.
=====
Eleven/CD
of/IN
the/DT
17/CD
patients/NNS
had/VBD
abnormal/JJ
karyotypes/NNS
./.
=====
The/DT
M-CSF/NN
gene/NN
was/VBD
expressed/VBN
in/IN
6/CD
cases/NNS
and/CC
the/DT
FMS/NN
and/CC
the/DT
EGR-1/NN
genes/NNS
were/VBD
expressed/VBN
in/IN
2/CD
of/IN
the/DT
latter/JJ
cases/NNS
./.
=====
An/DT
autocrine/JJ
mechanism/NN
of/IN
growth/NN
could/MD
be/VB
hypothesized/VBN
only/RB
for/IN
the/DT
2/CD
patients/NNS
whose/WP$
cells/NNS
expressed/VBD
both/CC
the/DT
M-CSF/NN
and/CC
FMS/NN
genes/NNS
./.
=====
No/DT
germline/NN
changes/NNS
or/CC
rearrangements/NNS
were/VBD
observed/VBN
in/IN
any/DT
of/IN
the/DT
genes/NNS
studied/VBN
./.
=====
Thus/RB
,/,
deregulation/NN
of/IN
genes/NNS
encoding/VBG
for/IN
certain/JJ
hemopoietic/JJ
growth/NN
factors/NNS
or/CC
receptors/NNS
does/VBZ
not/RB
seem/VB
to/TO
represent/VB
a/DT
major/JJ
mechanism/NN
of/IN
MDS/NN
progression/NN
./.